A Double-Blind Randomized Placebo Controlled Trial of Magnesium Oxide for Alleviation of Chronic Low Back Pain

Abstract

This double-blind randomized placebo controlled trial used a pre-test/post-test control group design. Sixty adults patients complaining of chronic low back pain (greater than six months) were recruited from a free standing major metropolitan pain center. Half of the patients received an oral 800mg magnesium oxide supplement and half received anoral placebo every day for a two-month trial period. Laboratory analysis of serum total magnesium, serum ionized magnesium, and sublingual (tissue) magnesium levels (Exatest, ICD Inc.) were performed before and after the trial. All patients were asked to assess their pain and various quality of life indicators using a 10 point Likert Scale before and after the trial.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 1999
Accession Number
AD1012239

Entities

People

  • Jeffrey L. Schrader

Organizations

  • Uniformed Services University of the Health Sciences

Tags

DTIC Thesaurus Topics

  • Analgesia
  • Anesthesia
  • Drug Abuse
  • Health Services
  • Medical Personnel
  • Pain
  • Pain Management
  • Pharmacies
  • Pharmacology

Fields of Study

  • Medicine

Readers

  • Materials Science and Engineering.
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.